Development Technology and astrocytes : J. Song et al., Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model, JCI, 2018, 128(1), 463-482
Development Technology and Pluripotent Stem Cells : K. Kim et al., Improved Isolation and Culture of Urine-Derived Stem Cells (USCs) and Enhanced Production of Immune Cells from the USC-Derived Induced Pluripotent Stem Cells, J. Clin. Med. (2020), 9, 827
Development Technology and Hematopoietic Progenitor Cells : K. Kim et al., 3,2’-Dihydroxyflavone Improves the Proliferation and Survival of Human Pluripotent Stem Cells and Their Differentiation into Hematopoietic Progenitor Cells, J. Clin. Med. (2020), 9, 669
Development Technology and mesenchymal stem cells : Lim et al., Glutathione dynamics determine the therapeutic efficacy of mesenchymal stem cells for graft-versus-host disease via CREB1-NRF2 pathway, Science Advances (2020), 6
Development Technology and senescent Cells : KB. Lee et al., Antioxidants reduce the heterogeneity of the intracellular glutathione level in senescent cell population of human dermal fibroblasts, J Dermatol Sci. (2020) 98(3),195-198
SOP of Development Technology : EM. Jeong et al., Monitoring Glutathione Dynamics and Heterogeneity in Living Stem Cells, Int J Stem Cells, (2019) 12(2), 367-379
Principles of Development Technology : EM. Jeong et al., Real-Time Monitoring of Glutathione in Living Cells Reveals that High Glutathione Levels Are Required to Maintain Stem Cell Function, Stem Cell Reports (2018), 10, 600-614
1